| Previous Close | 51.23 |
| Open | 51.24 |
| Bid | 51.47 x 100 |
| Ask | 51.55 x 100 |
| Day's Range | 50.79 - 51.72 |
| 52 Week Range | 34.58 - 65.91 |
| Volume | 27,381 |
| Avg. Volume | 391,426 |
| Market Cap | 1.75B |
| Beta | 1.47 |
| PE Ratio (TTM) | 44.11 |
| EPS (TTM) | 1.17 |
| Earnings Date | Nov 1, 2017 - Nov 6, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 55.30 |
- Zacks•1 hour ago
Why is Edwards Lifesciences (EW) a Strong Buy Stock Now?
Several recent FDA product-approvals boost investors' trust in Edwards Lifesciences' (EW) stock.
- Zacks•2 hours ago
Here's Why You Should Add Chemed (CHE) to Your Portfolio
Chemed (CHE) bolsters investor's confidence with continued strength in Roto-Rooter business.
- Zacks•3 hours ago
Here's Why You Should Bet on BioTelemetry (BEAT) Stock Now
BioTelemetry's (BEAT) consistent efforts in product innovation through research and development buoy optimism. Also, the recent acquisition instills confidence in investors.
